EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹5.55 Cr | ₹5.00 Cr | ₹4.91 Cr | ₹5.24 Cr | ₹5.55 Cr |
What is the latest Contingent Liabilities ratio of EVEREST ORGANICS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹5.55 Cr |
| Mar2024 | ₹5.00 Cr |
| Mar2023 | ₹4.91 Cr |
| Mar2022 | ₹5.24 Cr |
| Mar2021 | ₹5.55 Cr |
How is Contingent Liabilities of EVEREST ORGANICS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.55 Cr | 10.90 | |
| Mar2024 | ₹5.00 Cr | 1.83 | |
| Mar2023 | ₹4.91 Cr | -6.35 | |
| Mar2022 | ₹5.24 Cr | -5.50 | |
| Mar2021 | ₹5.55 Cr | - | |
Compare Contingent Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹262.3 Cr | 6.6% | 15.6% | -29.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | 6.6% |
15.6% |
-29.2% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses